Results 171 to 180 of about 7,248 (208)

Naloxone Dispensing to Youth Ages 10-19: 2017-2022. [PDF]

Pediatrics
Terranella A, Guy G, Mikosz C.
europepmc   +1 more source

GnRH Peptide Antagonist: Comparative Analysis of Chemistry and Formulation with Implications for Clinical Safety and Efficacy. [PDF]

Pharmaceuticals (Basel)
Patel S, Saxena B, Mehta P, Niazi SK.
europepmc   +1 more source

Increasing take-home naloxone kit distribution to patients with substance use disorder before hospital discharge: a quality improvement project. [PDF]

BMJ Open Qual
Wong D, Jia L.
europepmc   +1 more source

Take-home naloxone administered in emergency settings: feasibility of intervention implementation in a cluster randomized trial. [PDF]

BMC Emerg Med
Snooks HA, Jones JK, Bell FB, Benger JR, Black SL, Dixon S, Edwards A, Emery H, Evans BA, Fuller GW, Goodacre S, Hoskins R, Hughes J, John A, Johnston S, Jones MB, Moore CR, Parab R, Pilbery R, Sampson FC, Watkins A.   +20 more
europepmc   +1 more source

Teneurin C-terminal associated peptide (TCAP)-1 attenuates the development and expression of naloxone-precipitated morphine withdrawal in male Swiss Webster mice. [PDF]

Psychopharmacology (Berl)
Mueller LE, Wexler RS, Lovejoy DA, Stein RB, Slee AM.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Narcotic Antagonists as Analgesics

Science, 1962
2-Dimethylallyl-5,9-dimethyl-2′-hydroxybenzomorphan (Win 20,228) was found to be a weak antagonist of morphine and meperidine, whereas 2-allyl-5-ethyl-2′-hydroxy-9-methyl-6,7-benzomorphan (Win 19,362) and 2-allyl-2′-hydroxy-5,9-dimethyl-6,7-benzomorphan (Win 19,631) were about three times as potent as nalorphine.
Jane Telford, J. G. Bird, Anne K. Pierson, Louis S. Harris, Sydney Archer, Noel F. Albertson, Arthur S. Keats, C. N. Papadopoulos   +7 more
openaire   +3 more sources

COMPARATIVE STUDIES WITH NARCOTICS AND NARCOTIC ANTAGONISTS IN MAN

Acta Anaesthesiologica Scandinavica, 1964
ZUSAMMENFASSUNGBei 240 oberflächlich anaesthesierten Patienten, die keine Narkotika als Prämedikation erhalten hatten, wurden die Wirkungen auf Atmung und Kreislauf der folgenden Mittel, allein oder in verschiedenen Kombinationen verabreicht, untersucht: Morphin (0,2 oder 0,3 mg/kg), Oxymorphon(20 μ/kg),Levorphan (50μ/kg),Meperidin (1,5 und 2,0 mg/kg ...
T. A. G. Torda, Francis F. Foldes
openaire   +3 more sources

EVALUATION OF NARCOTIC AND NARCOTIC ANTAGONIST INTERACTIONS IN PRIMATES*

Annals of the New York Academy of Sciences, 1976
Multiple and single drug interactions were studied in morphine-dependent monkeys whose dependency was maintained by self-infusion. Naloxone, naltrexone, and cyclazocine precipitated abstinence syndrome which the animals generally controlled with increased morphine intake.
C. A. Robinson, M. J. Brocco, K. F. Killam   +2 more
openaire   +3 more sources

CLINICAL PHARMACOLOGY OF NARCOTIC ANTAGONISTS*

Annals of the New York Academy of Sciences, 1978
Both naloxone and naltrexone are effective narcotic antagonists with minimal agonistic effects and a wide margin of safety. Naloxone is useful in the treatment of narcotic overdose and it is helpful in the quantification of physical dependence. Naltrexone is pharmacologically successful as an orally effective, long-acting antagonist but its clinical ...
Joseph W. Ternes, Robert A. Greenstein, Charles P. O'Brien, George E. Woody   +3 more
openaire   +3 more sources